Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$11.62 USD
+0.12 (1.04%)
Updated May 14, 2024 04:00 PM ET
After-Market: $11.71 +0.09 (0.77%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Precision BioSciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 49 | 25 | 116 | 24 | 22 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 49 | 25 | 116 | 24 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 92 | 125 | 155 | 134 | 109 |
Income After Depreciation & Amortization | -44 | -100 | -39 | -110 | -87 |
Non-Operating Income | 3 | -10 | 9 | 1 | -5 |
Interest Expense | 2 | 1 | 0 | 0 | 0 |
Pretax Income | -43 | -112 | -31 | -109 | -93 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -43 | -112 | -31 | -109 | -93 |
Extras & Discontinued Operations | -19 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -61 | -112 | -31 | -109 | -93 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -36 | -92 | -29 | -100 | -82 |
Depreciation & Amortization (Cash Flow) | 8 | 9 | 10 | 10 | 5 |
Income After Depreciation & Amortization | -44 | -100 | -39 | -110 | -87 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3.84 | 2.93 | 1.95 | 1.73 | 1.40 |
Diluted EPS Before Non-Recurring Items | -11.07 | -38.14 | -15.62 | -62.76 | -57.36 |
Diluted Net EPS (GAAP) | -15.96 | -38.14 | -15.62 | -62.76 | -66.37 |
Fiscal Year end for Precision BioSciences, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7.04 | 13.12 | 19.79 | 8.78 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 7.04 | 13.12 | 19.79 | 8.78 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.96 | 25.48 | 31.78 | 33.25 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.08 | -12.36 | -11.99 | -24.47 |
Non-Operating Income | NA | -0.08 | 0.83 | 0.65 | -0.07 |
Interest Expense | NA | 0.58 | 0.58 | 0.55 | 0.52 |
Pretax Income | NA | 6.53 | -12.11 | -11.89 | -25.06 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 6.53 | -12.11 | -11.89 | -25.06 |
Extras & Discontinued Operations | NA | -22.82 | 4.03 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -16.29 | -8.08 | -11.89 | -25.06 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 4.01 | 3.84 | 3.80 | 3.71 |
Diluted EPS Before Non-Recurring Items | NA | -3.35 | -3.00 | -3.00 | -6.91 |
Diluted Net EPS (GAAP) | NA | -3.95 | -2.10 | -3.00 | -6.91 |